Skip to main content
Published locations for T2D: Noninferior efficacy with adding low-dose vs. standard-dose lobeglitazone to metformin and DPP4i
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
T2D: Noninferior efficacy with adding low-dose vs. standard-dose lobeglitazone to metformin and DPP4i
User login
Username
Password
Reset your password
/content/t2d-noninferior-efficacy-adding-low-dose-vs-standard-dose-lobeglitazone-metformin-and-dpp4i
/type-2-diabetes-icymi/article/255614/diabetes/t2d-noninferior-efficacy-adding-low-dose-vs-standard